Clinical laboratory NEXT Bio-Research Services LLC, doing business as NEXT Molecular Analytics, of Chester, Virginia, has agreed to pay at least $758,000 to the United States to resolve False Claims Act allegations involving illegal kickbacks to doctors and marketers. NEXT has agreed to cooperate with the Department of Justice’s investigations of, and litigation against, other participants in the alleged schemes. Under the settlement with the United States, NEXT has agreed to pay $758,000, plus additional amounts if certain financial contingencies occur. The settlement resolves allegations that NEXT knowingly and willfully paid kickbacks to induce laboratory testing referrals. NEXT allegedly paid doctors in Texas and Arkansas thousands of dollars in kickbacks, which were disguised as consulting fees and medical director fees but actually were offered to induce the doctor to order NEXT laboratory tests. NEXT also allegedly paid commissions based on the volume and value of referrals to certain independent contractor marketers to arrange for and recommend that doctors order NEXT laboratory tests. The settlement resolves allegations that NEXT billed Medicare, Medicaid, and TRICARE for the laboratory tests despite knowing of these kickbacks.